Pharmacovigilance programme of India
The monitoring and reporting of adverse drug reactions (ADRs) through pharmacovigilance is vital to patient safety and rational prescribing. In India, Central Drugs Standard Control Organization (CDSCO) initiated Pharmacovigilance Programme of India (PvPI) to report ADRs through ADRs monitoring cent...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Archives of Global Professionals
2012-01-01
|
| Series: | Archives of Pharmacy Practice |
| Subjects: | |
| Online Access: | http://www.archivepp.com/article.asp?issn=2045-080X;year=2012;volume=3;issue=3;spage=229;epage=232;aulast=Vivekanandan;type=0 |
| _version_ | 1819014674760335360 |
|---|---|
| author | Kalaiselvan Vivekanandan Jai Prakash Gyanendra Nath Singh |
| author_facet | Kalaiselvan Vivekanandan Jai Prakash Gyanendra Nath Singh |
| author_sort | Kalaiselvan Vivekanandan |
| collection | DOAJ |
| description | The monitoring and reporting of adverse drug reactions (ADRs) through pharmacovigilance is vital to patient safety and rational prescribing. In India, Central Drugs Standard Control Organization (CDSCO) initiated Pharmacovigilance Programme of India (PvPI) to report ADRs through ADRs monitoring centres in India. Indian Pharmacopoeia Commission (IPC) is functioning as National Coordination Centre (NCC) for PvPI. The ADRs are reported to NCC through VigiFlow by various centres are evaluated and committed to Uppsala Monitoring Centre, Sweden. The potential benefit of the PvPI is aimed to reducing or eliminating a harm of medicine. Continuous efforts of the healthcare professionals and the patients are expected to make this as one of the most successful and effective programmes. The present article updates the status and future plan of PvPI. |
| first_indexed | 2024-12-21T02:19:36Z |
| format | Article |
| id | doaj.art-b2d569c167f34417867014df6bc70387 |
| institution | Directory Open Access Journal |
| issn | 2045-080X |
| language | English |
| last_indexed | 2024-12-21T02:19:36Z |
| publishDate | 2012-01-01 |
| publisher | Archives of Global Professionals |
| record_format | Article |
| series | Archives of Pharmacy Practice |
| spelling | doaj.art-b2d569c167f34417867014df6bc703872022-12-21T19:19:11ZengArchives of Global ProfessionalsArchives of Pharmacy Practice2045-080X2012-01-013322923210.4103/2045-080X.116605Pharmacovigilance programme of IndiaKalaiselvan VivekanandanJai PrakashGyanendra Nath SinghThe monitoring and reporting of adverse drug reactions (ADRs) through pharmacovigilance is vital to patient safety and rational prescribing. In India, Central Drugs Standard Control Organization (CDSCO) initiated Pharmacovigilance Programme of India (PvPI) to report ADRs through ADRs monitoring centres in India. Indian Pharmacopoeia Commission (IPC) is functioning as National Coordination Centre (NCC) for PvPI. The ADRs are reported to NCC through VigiFlow by various centres are evaluated and committed to Uppsala Monitoring Centre, Sweden. The potential benefit of the PvPI is aimed to reducing or eliminating a harm of medicine. Continuous efforts of the healthcare professionals and the patients are expected to make this as one of the most successful and effective programmes. The present article updates the status and future plan of PvPI.http://www.archivepp.com/article.asp?issn=2045-080X;year=2012;volume=3;issue=3;spage=229;epage=232;aulast=Vivekanandan;type=0PharmacovigilanceADRsVigiFlowIndian Pharmacopoeia CommissionCentral Drugs Standard Control Organization |
| spellingShingle | Kalaiselvan Vivekanandan Jai Prakash Gyanendra Nath Singh Pharmacovigilance programme of India Archives of Pharmacy Practice Pharmacovigilance ADRs VigiFlow Indian Pharmacopoeia Commission Central Drugs Standard Control Organization |
| title | Pharmacovigilance programme of India |
| title_full | Pharmacovigilance programme of India |
| title_fullStr | Pharmacovigilance programme of India |
| title_full_unstemmed | Pharmacovigilance programme of India |
| title_short | Pharmacovigilance programme of India |
| title_sort | pharmacovigilance programme of india |
| topic | Pharmacovigilance ADRs VigiFlow Indian Pharmacopoeia Commission Central Drugs Standard Control Organization |
| url | http://www.archivepp.com/article.asp?issn=2045-080X;year=2012;volume=3;issue=3;spage=229;epage=232;aulast=Vivekanandan;type=0 |
| work_keys_str_mv | AT kalaiselvanvivekanandan pharmacovigilanceprogrammeofindia AT jaiprakash pharmacovigilanceprogrammeofindia AT gyanendranathsingh pharmacovigilanceprogrammeofindia |